Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2020

Nov 3, 2020

284_dirs_2020-11-03_924c890e-2ba7-4228-b44a-2ddc31f2d4d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-10-30

Reporting Person: MIZELL STEVEN (EVP, Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-30 Common Stock M 4574 $75.89 Acquired 7624.145 Direct
2020-10-30 Common Stock F 2273 $75.89 Disposed 5351.145 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-10-30 Restricted Stock Unit $ M 4574 Disposed 2021-10-30 Common Stock (4574) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.